China Reinsurance (Group) (1508) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
15 Sep, 2026Executive summary
Unaudited financial data for the nine months ended 30 September 2024 were disclosed, prepared under PRC Accounting Standards for Business Enterprises.
Disclosure is in line with regulatory requirements following the issuance of RMB5.0 billion capital supplementary bonds.
Financial highlights
Total assets reached RMB285.38 billion as of 30 September 2024.
Net profit for the period was RMB979.94 million.
Gross written premium amounted to RMB56.16 billion for the nine-month period.
Investment income totaled RMB4.15 billion.
Total liabilities stood at RMB262.71 billion, with owners' equity at RMB22.67 billion.
Segment performance
Premiums earned were RMB43.72 billion, with reinsurance premium income at RMB39.17 billion.
Claims paid reached RMB18.39 billion, with claims recoverable from reinsurers at RMB11.82 billion.
Change in insurance contract reserves was RMB34.22 billion, offset by RMB5.97 billion recoverable from reinsurers.
Latest events from China Reinsurance (Group)
- Net profit attributable to equity holders surged 184.6% on 6.8% higher insurance revenue.1508
Q2 2024 - Net profit surged 86.8% year-on-year, with record premiums and strong investment returns.1508
Q4 2024 - Q1 2025 net profit was RMB620.87 million on RMB9.98 billion operating income.1508
Q1 2025 - Net profit reached RMB2.95 billion on assets of RMB321.0 billion for the nine months ended September 2025.1508
Q3 2025 - Record profits, premiums, and dividends in 2025, with strong digital and global expansion.1508
Q4 2025 - Net profit up 15.1% to RMB7,596 million, driven by growth in life and health reinsurance.1508
Q2 2026 - Q1 2026 net profit reached RMB336.9 million on assets of RMB94.1 billion.1508
Q1 2026 - Net profit up 11.4% to RMB 6,599m, with robust solvency and mixed segment performance.1508
Q2 2025